Back to top
more

PRESTIGE CONSMR (PBH)

(Delayed Data from NYSE)

$70.38 USD

70.38
320,284

-0.53 (-0.75%)

Updated Jul 24, 2024 04:00 PM ET

After-Market: $70.41 +0.03 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (103 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for PBH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Prestige Consumer Healthcare Inc falls in the month of March.

All items in Millions except Per Share data.

3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Assets          
Cash & Equivalents 46 58 27 32 95
Receivables 177 167 139 115 151
Notes Receivable 0 0 0 0 0
Inventories 139 162 120 115 116
Other Current Assets 13 4 6 8 4
Total Current Assets 375 392 293 270 366
Net Property & Equipment 77 70 71 70 56
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 2,848 2,869 3,276 3,054 3,055
Deposits & Other Assets 6 3 3 3 3
Total Assets 3,318 3,354 3,671 3,429 3,514
Liabilities & Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 39 63 56 46 62
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 1 3 3 3 1
Accrued Expenses 72 88 79 68 81
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 117 161 143 122 150
Mortgages 0 0 0 0 0
Deferred Taxes/Income 404 380 445 434 408
Convertible Debt 0 0 0 0 0
Long-Term Debt 1,126 1,346 1,477 1,480 1,730
Non-Current Capital Leases 0 2 5 7 5
Other Non-Current Liabilities 9 8 7 9 25
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,663 1,907 2,093 2,071 2,343
Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 567 535 516 500 488
Retained Earnings 1,341 1,132 1,214 1,009 844
Other Equity -35 -32 -19 -20 -44
Treasury Stock 220 189 134 131 118
Total Shareholder's Equity 1,655 1,447 1,578 1,358 1,171
Total Liabilities & Shareholder's Equity 3,318 3,354 3,671 3,429 3,514
Total Common Equity 1,655 1,447 1,578 1,358 1,171
Shares Outstanding 49.60 49.60 50.20 49.80 50.20
Book Value Per Share 33.37 29.18 31.43 27.28 23.33

Fiscal Year End for Prestige Consumer Healthcare Inc falls in the month of March.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 46 64 60 55
Receivables NA 177 174 158 158
Notes Receivable NA 0 0 0 0
Inventories NA 139 149 161 170
Other Current Assets NA 13 7 8 9
Total Current Assets NA 375 394 388 392
Net Property & Equipment NA 77 70 71 70
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 2,848 2,856 2,855 2,864
Deposits & Other Assets NA 6 6 4 3
Total Assets NA 3,318 3,340 3,333 3,346
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 39 39 44 58
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 1 2 3 3
Accrued Expenses NA 72 80 76 80
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 117 127 130 147
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 404 397 388 384
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,126 1,199 1,263 1,317
Non-Current Capital Leases NA 0 0 0 1
Other Non-Current Liabilities NA 9 9 8
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,663 1,739 1,797 1,865
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 567 556 552 547
Retained Earnings NA 1,341 1,292 1,239 1,185
Other Equity NA -35 -29 -36 -32
Treasury Stock NA 220 220 220 220
Total Shareholder's Equity NA 1,655 1,601 1,536 1,480
Total Liabilities & Shareholder's Equity NA 3,318 3,340 3,333 3,346
Total Common Equity 0 1,655 1,601 1,536 1,480
Shares Outstanding 49.90 49.60 49.60 49.60 49.50
Book Value Per Share 0.00 33.37 32.27 30.97 29.91